BridgeMD
New treatment option for Borderline Personality Disorder
Official title Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder
ClinicalTrials.gov ID: NCT06446765
What this study is testing
- What it's testing
- The purpose of this study is to test the ability of mindfulness-based real time functional magnetic resonance imaging (fMRI) neurofeedback (mbNF) to increase the benefits of evidence-based psychotherapy for adults with Borderline Personality Disorder (BPD).
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- age 18-60,
- be able to provide written informed consent,
- meet criteria for BPD on semi-structured clinical interview,
- able to plan to keep any prescribed medications and psychotherapy constant during the study
- fluent in English.
You likely can't join if
- current DBT psychotherapy outside the study
- lifetime primary psychotic disorder
- manic episode in the last one year
- developmental disorder (e.g. autism)
- history of learning disorder
- severe substance use disorder in the last 3 months
See the full eligibility criteria
- age 18-60,
- be able to provide written informed consent,
- meet criteria for BPD on semi-structured clinical interview,
- able to plan to keep any prescribed medications and psychotherapy constant during the study
- fluent in English.
- current DBT psychotherapy outside the study
- lifetime primary psychotic disorder
- manic episode in the last one year
- developmental disorder (e.g. autism)
- history of learning disorder
- severe substance use disorder in the last 3 months
- active suicidal ideation with intent or plan in the past 3 months
- history of major medical or neurologic disorder
- MRI contraindications, including pregnancy
- poor performance on reading task (WRAT \> 11 errors)
- newly prescribed medications in the past 8 weeks
- daytime sedating medications (e.g. benzodiazepines, opiates, sedating neuroleptics)
- any scheduled daily benzodiazepines
- change in psychotherapy type or frequency in the past 12 weeks.
- At the discretion of the study PI Eligibility will be determined by study personnel.
The study team makes the final eligibility decision.
Where it's taking place
- New Haven, Connecticut, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Haven, Connecticut, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.